1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pharmaceutical Excipients Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pharmaceutical Excipients Market, by Functionality
8.1.1. Fillers and Diluents
8.1.1.1. Market Revenue and Forecast
8.1.2. Suspending and Viscosity Agents
8.1.2.1. Market Revenue and Forecast
8.1.3. Coating Agents
8.1.3.1. Market Revenue and Forecast
8.1.4. Binders
8.1.4.1. Market Revenue and Forecast
8.1.5. Disintegrants
8.1.5.1. Market Revenue and Forecast
8.1.6. Colorants
8.1.6.1. Market Revenue and Forecast
8.1.7. Lubricants and Glidants
8.1.7.1. Market Revenue and Forecast
8.1.8. Preservatives
8.1.8.1. Market Revenue and Forecast
8.1.9. Emulsifying Agents
8.1.9.1. Market Revenue and Forecast
8.1.10. Flavoring Agents and Sweeteners
8.1.10.1. Market Revenue and Forecast
8.1.11. Other Functionalities
8.1.12.1. Market Revenue and Forecast
9.1. Pharmaceutical Excipients Market, by Excipient Type
9.1.1. Lactose-based Excipients
9.1.1.1. Market Revenue and Forecast
9.1.2. Cellulose-based
9.1.2.1. Market Revenue and Forecast
9.1.3. Starches
9.1.3.1. Market Revenue and Forecast
9.1.4. Carboxymethylcellulose Sodium (CCS)
9.1.4.1. Market Revenue and Forecast
9.1.5. Sodium Starch Glycolate (SSG)
9.1.5.1. Market Revenue and Forecast
9.1.6. Fine Chemicals
9.1.6.1. Market Revenue and Forecast
9.1.7. Mannitol
9.1.7.1. Market Revenue and Forecast
9.1.8. Biopharma Excipients
9.1.8.1. Market Revenue and Forecast
9.1.9. Others
9.1.9.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Functionality
10.1.2. Market Revenue and Forecast, by Excipient Type
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Functionality
10.1.3.2. Market Revenue and Forecast, by Excipient Type
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Functionality
10.1.4.2. Market Revenue and Forecast, by Excipient Type
10.2. Europe
10.2.1. Market Revenue and Forecast, by Functionality
10.2.2. Market Revenue and Forecast, by Excipient Type
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Functionality
10.2.3.2. Market Revenue and Forecast, by Excipient Type
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Functionality
10.2.4.2. Market Revenue and Forecast, by Excipient Type
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Functionality
10.2.5.2. Market Revenue and Forecast, by Excipient Type
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Functionality
10.2.6.2. Market Revenue and Forecast, by Excipient Type
10.3. APAC
10.3.1. Market Revenue and Forecast, by Functionality
10.3.2. Market Revenue and Forecast, by Excipient Type
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Functionality
10.3.3.2. Market Revenue and Forecast, by Excipient Type
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Functionality
10.3.4.2. Market Revenue and Forecast, by Excipient Type
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Functionality
10.3.5.2. Market Revenue and Forecast, by Excipient Type
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Functionality
10.3.6.2. Market Revenue and Forecast, by Excipient Type
10.4. MEA
10.4.1. Market Revenue and Forecast, by Functionality
10.4.2. Market Revenue and Forecast, by Excipient Type
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Functionality
10.4.3.2. Market Revenue and Forecast, by Excipient Type
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Functionality
10.4.4.2. Market Revenue and Forecast, by Excipient Type
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Functionality
10.4.5.2. Market Revenue and Forecast, by Excipient Type
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Functionality
10.4.6.2. Market Revenue and Forecast, by Excipient Type
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Functionality
10.5.2. Market Revenue and Forecast, by Excipient Type
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Functionality
10.5.3.2. Market Revenue and Forecast, by Excipient Type
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Functionality
10.5.4.2. Market Revenue and Forecast, by Excipient Type
11.1. BASF SE
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Ashland Global Holdings Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. DuPont de Nemours Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Roquette Frères SA
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Evonik Industries AG
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Archer Daniels Midland Co.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Kerry Group plc
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. The Lubrizol Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Air Liquide SA
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Croda International plc
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
